Publication:
Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patients

dc.contributor.authorFerreira, João Pedro
dc.contributor.authorRosselló, Xavier
dc.contributor.authorZannad, Faiez
dc.date.accessioned2024-10-09T06:35:15Z
dc.date.available2024-10-09T06:35:15Z
dc.date.issued2023-11-27
dc.descriptionThis is a postprint (Accepted Manuscript) of an article published by Wiley in European Journal of Heart Failure on 2023 December 20, available online: https://doi.org/10.1002/ejhf.3098
dc.identifier.citationFerreira JP, Rossello X, Zannad F. Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patients. Eur J Heart Fail. 2023 Dec 20.en
dc.identifier.doi10.1002/ejhf.3098
dc.identifier.e-issn1879-0844es_ES
dc.identifier.journalEuropean journal of heart failurees_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/20090
dc.identifier.pubmedID38013392es_ES
dc.identifier.puiL2027214705
dc.identifier.scopus2-s2.0-85180172810
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23716
dc.identifier.wos1128004600001
dc.language.isoengen
dc.publisherWiley
dc.relation.publisherversionhttps://doi.org/10.1002/ejhf.3098en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleMineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patientsen
dc.typeeditorialen
dc.type.hasVersionSMURes_ES
dspace.entity.typePublication
relation.isPublisherOfPublicationd81e762a-95f7-4917-88a1-8004b3b8caa7
relation.isPublisherOfPublication.latestForDiscoveryd81e762a-95f7-4917-88a1-8004b3b8caa7

Files